Skip to content

Ardelyx ARDX Financing Cash Flow

Financing Cash Flow at other companies

Amgen logo
AmgenAMGN
$1.44B+135%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$100M+31.5%
AbbVie logo
AbbVieABBV
$919M+173%
XER
Xeris Biopharma Holdings, Inc.XERS
-$8.84M-182%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$1.39M+253%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
-$86.1M+27.0%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's financing cash flow?
Ardelyx (ARDX) reported financing cash flow of $5.44M in Q1 2026.
How has Ardelyx's financing cash flow changed year-over-year?
Ardelyx's financing cash flow increased by 267.2% year-over-year, from $1.48M to $5.44M.
What is the long-term trend for Ardelyx's financing cash flow?
Over 4 years (2021 to 2025), Ardelyx's financing cash flow has grown at a -10.0% compound annual growth rate (CAGR), from $83M to $54.51M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.